DAFNA Capital Management LLC Sells 4,000 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

DAFNA Capital Management LLC lessened its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 397,505 shares of the exchange traded fund’s stock after selling 4,000 shares during the period. SPDR S&P Biotech ETF comprises 9.1% of DAFNA Capital Management LLC’s portfolio, making the stock its largest holding. DAFNA Capital Management LLC owned approximately 0.52% of SPDR S&P Biotech ETF worth $35,799,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Golden State Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $29,000. Kohmann Bosshard Financial Services LLC purchased a new position in SPDR S&P Biotech ETF during the fourth quarter worth approximately $29,000. Avior Wealth Management LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares during the last quarter. Lee Danner & Bass Inc. purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $38,000. Finally, Bank of Jackson Hole Trust acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth $43,000.

SPDR S&P Biotech ETF Trading Up 0.2 %

Shares of SPDR S&P Biotech ETF stock opened at $77.35 on Thursday. The business’s fifty day moving average price is $81.12 and its 200 day moving average price is $89.56. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $105.47. The stock has a market capitalization of $4.91 billion, a P/E ratio of 11.47 and a beta of 1.00.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.